A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.

Saved in:

Bibliographic Details
Title:	A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.
Authors:	Platt, Adam¹ adam.platt@astrazeneca.com, Morten, John², Qunsheng Ji³, Elvin, Paul², Womack, Chris², Xinying Su³, Donald, Emma², Gray, Neil², Read, Jessica², Bigley, Graham², Blockley, Laura², Cresswell, Carl², Dale, Angela², Davies, Amanda², Tianwei Zhang³, Shuqiong Fan³, Haihua Fu³, Gladwin, Amanda², Harrod, Grace², Stevens, James²
Source:	BMC Cancer. 2015, Vol. 15 Issue 1, p1-10. 10p.
Database:	Academic Search Ultimate

Description
ISSN:	14712407
DOI:	10.1186/s12885-015-1146-8